Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$8K Sell
132
-1,437
-92% -$94.4K 0.39% 78
2016
Q4
$105K Buy
1,569
+616
+65% +$39.2K 0.5% 68
2016
Q3
$50K Buy
953
+516
+118% +$27.6K 0.25% 128
2016
Q2
$24K Buy
+437
New +$23K 0.12% 178
2016
Q1
Sell
-1,168
Closed -$61K 254
2015
Q4
$61K Buy
+1,168
New +$71.8K 0.26% 130

Other funds holding AKAM

New York Life Trust's AKAM Position: Q1 2017 in Review

New York Life Trust reduced its Akamai (AKAM) stake by 92% in Q1 2017, selling an estimated $94.4K and leaving 132 shares worth $8K. The position accounts for 0.39% of the portfolio, ranked #78.

New York Life Trust first reported a position in AKAM in Q4 2015 and has held it in 5 quarters since. The position peaked at $105K in Q4 2016. 547 funds tracked by Wall St. Rank hold AKAM as of Q1 2017.

  • New York Life Trust held 132 shares of Akamai worth $8K as of Q1 2017.
  • New York Life Trust sold 1,437 Akamai shares in Q1 2017, an estimated $94.4K.
  • Akamai made up 0.39% of New York Life Trust's portfolio in Q1 2017, its #78 holding.
  • New York Life Trust first reported a position in Akamai in Q4 2015 and has held it in 5 quarters since.
  • New York Life Trust's Akamai position peaked at $105K in Q4 2016.
  • 547 funds tracked by Wall St. Rank held Akamai as of Q1 2017.

Based on New York Life Trust's 13F filing for Q1 2017, filed 12 May 2017.